IN2014DN10550A - - Google Patents
Info
- Publication number
- IN2014DN10550A IN2014DN10550A IN10550DEN2014A IN2014DN10550A IN 2014DN10550 A IN2014DN10550 A IN 2014DN10550A IN 10550DEN2014 A IN10550DEN2014 A IN 10550DEN2014A IN 2014DN10550 A IN2014DN10550 A IN 2014DN10550A
- Authority
- IN
- India
- Prior art keywords
- cerium oxide
- multiple sclerosis
- oxide nanoparticles
- biocompatible
- nanoparticles
- Prior art date
Links
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
- 239000002105 nanoparticle Substances 0.000 abstract 3
- 229910000420 cerium oxide Inorganic materials 0.000 abstract 2
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 abstract 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 abstract 1
- 206010063837 Reperfusion injury Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 abstract 1
- 239000000560 biocompatible material Substances 0.000 abstract 1
- 208000007118 chronic progressive multiple sclerosis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000006185 dispersion Substances 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 abstract 1
- 230000000302 ischemic effect Effects 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 239000007800 oxidant agent Substances 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 230000036542 oxidative stress Effects 0.000 abstract 1
- 239000011541 reaction mixture Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/64—Nanometer sized, i.e. from 1-100 nanometer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nanotechnology (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261689806P | 2012-06-13 | 2012-06-13 | |
| US201261690100P | 2012-06-18 | 2012-06-18 | |
| US201261795241P | 2012-10-12 | 2012-10-12 | |
| US201261796639P | 2012-11-16 | 2012-11-16 | |
| PCT/US2013/032318 WO2013187980A1 (fr) | 2012-06-13 | 2013-03-15 | Nanoparticules d'oxyde de cérium pour le traitement du stress oxydatif |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN10550A true IN2014DN10550A (fr) | 2015-08-21 |
Family
ID=48048227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN10550DEN2014 IN2014DN10550A (fr) | 2012-06-13 | 2013-03-15 |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US9034392B2 (fr) |
| EP (1) | EP2861212B1 (fr) |
| JP (1) | JP6174692B2 (fr) |
| KR (1) | KR101990070B1 (fr) |
| CN (1) | CN104812375B (fr) |
| AU (1) | AU2013274901B2 (fr) |
| CA (1) | CA2875206C (fr) |
| DK (1) | DK2861212T3 (fr) |
| ES (1) | ES2617528T3 (fr) |
| IN (1) | IN2014DN10550A (fr) |
| MX (1) | MX2014015251A (fr) |
| WO (1) | WO2013187980A1 (fr) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2014DN10550A (fr) | 2012-06-13 | 2015-08-21 | Cerion Entpr Llc | |
| US9446070B2 (en) * | 2012-06-13 | 2016-09-20 | Cerion, Llc | Nanoceria with citric acid additive |
| AU2014256983B2 (en) | 2013-04-25 | 2018-10-04 | Cerion Enterprises, Llc | Chelated nanoceria for the treatment of oxidative stress |
| US10182994B2 (en) * | 2014-06-10 | 2019-01-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Nanoparticulate complex of nicotine and cerium oxide and use thereof |
| BR112017000800A8 (pt) * | 2014-07-17 | 2023-04-25 | Biocurity Holdings Inc | Tratamento do câncer com uma combinação de radiação, nanoparticulas de óxido de cério, e um agente quimioterápico |
| JP2018508568A (ja) | 2015-01-20 | 2018-03-29 | セリオン,リミティド ライアビリティ カンパニー | カタラーゼ様活性を有するeddsでキレート化されたナノセリア |
| KR101765557B1 (ko) | 2015-02-27 | 2017-08-23 | 서울대학교산학협력단 | 생흡수성 전자 스텐트 |
| US11389536B2 (en) | 2015-07-17 | 2022-07-19 | BioCurity Pharmaceuticals Inc. | Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent |
| EP3380088A4 (fr) * | 2015-11-25 | 2019-07-31 | The Regents of the University of Colorado, A Body Corporate | Utilisation de microarn-146a et d'un conjugué de nanoparticules d'oxyde de cérium pour améliorer la cicatrisation et promouvoir la régénération tissulaire |
| AU2017384425B2 (en) * | 2016-12-21 | 2023-08-31 | Nanobiotix | Nanoparticles for use for treating a neuronal disorder |
| AU2018390163B2 (en) | 2017-12-19 | 2024-05-02 | Nanobiotix | Nanoparticles for use in enhancing brain performances or in treating stress |
| HUE068741T2 (hu) | 2017-12-19 | 2025-01-28 | Nanobiotix | Nanorészecskék idegi zavarok kezelésére |
| WO2020069292A1 (fr) * | 2018-09-28 | 2020-04-02 | The Regents Of The University Of Colorado, A Body Corporate | Méthode de prévention et de traitement de l'inflammation et de la fibrose pulmonaire |
| CN111333098B (zh) * | 2018-11-30 | 2022-04-19 | 中国科学院大连化学物理研究所 | 二氧化铈纳米立方块的制备方法 |
| CN109806278B (zh) * | 2019-02-01 | 2021-08-10 | 浙江大学 | 磷脂聚乙二醇修饰的超小型氧化铈纳米晶的应用 |
| FR3093640B1 (fr) * | 2019-03-15 | 2021-10-01 | Biophytis | Phytoecdysones et leurs dérivés pour leur utilisation dans le traitement de maladies neuromusculaires |
| CN109939125B (zh) * | 2019-04-22 | 2021-05-18 | 南昌大学第二附属医院 | 一种抗氧化剂及其制备方法与应用 |
| FR3098723B1 (fr) * | 2019-07-18 | 2023-01-13 | Bionuclei | Traitement ecobiologique des effets secondaires de la radiotherapie. |
| KR102107760B1 (ko) * | 2019-08-28 | 2020-05-07 | 한국콜마주식회사 | 피부 장벽 강화, 피부 보습 및/또는 미세 먼지 차단용 세륨옥사이드 분산액 및 이를 포함하는 화장료 조성물 |
| JP7740020B2 (ja) * | 2020-05-27 | 2025-09-17 | 東レ株式会社 | 酸化セリウムのナノ粒子、抗菌剤、抗ウイルス剤および酸化セリウムのナノ粒子の製造方法 |
| CN111773243B (zh) * | 2020-07-17 | 2022-09-23 | 南京大学 | 炎症性肠病的药物及其制备方法和用途 |
| CN112007016B (zh) * | 2020-09-07 | 2021-07-23 | 南京大学 | 一种纳米缓释制剂及其制备方法和在制备治疗线粒体功能障碍疾病的药物中的应用 |
| CN112494513A (zh) * | 2020-12-15 | 2021-03-16 | 中国药科大学 | 一种二氧化铈纳米粒及其制备方法与应用 |
| CN112516294B (zh) * | 2020-12-22 | 2023-04-07 | 浙江大学 | 一种氧化铈纳米稳定剂在制备预防过敏性疾病药物中的应用及预防过敏性疾病的药物组合物 |
| CN113546093A (zh) * | 2021-07-20 | 2021-10-26 | 中国人民解放军陆军军医大学 | 氧化铈纳米颗粒在制备治疗和预防肾缺血再灌注损伤的药物中的应用 |
| CN113842469B (zh) * | 2021-08-25 | 2024-04-02 | 中国科学院过程工程研究所 | 一种囊泡表面原位结晶高催化活性铈纳米晶的递药系统及其制备方法和应用 |
| CN114470326B (zh) * | 2021-12-06 | 2022-09-13 | 中国人民解放军空军军医大学 | 一种仿生矿化胶原-糖胺聚糖材料制备方法及其应用 |
| KR102810481B1 (ko) * | 2022-01-21 | 2025-05-19 | 성균관대학교산학협력단 | 다발성경화증 치료용 백신 |
| US12521414B2 (en) * | 2022-06-08 | 2026-01-13 | National Health Research Institutes | Method for preventing or treating urological chronic pelvic pain syndrome |
| CN116270729A (zh) * | 2022-11-09 | 2023-06-23 | 西安交通大学医学院第一附属医院 | 多孔纳米棒状氧化铈在制备治疗特应性皮炎的药物中的应用 |
| CN115737678B (zh) * | 2022-11-30 | 2024-12-20 | 浙江大学金华研究院 | 载三苯基膦修饰的氧化铈和全反式维甲酸的脂质体凝胶 |
| CN116180065B (zh) * | 2022-12-27 | 2024-10-08 | 国科大杭州高等研究院 | 一种表面改性的镍钛合金材料及其制备方法和应用 |
| CN116036127B (zh) * | 2023-01-17 | 2025-09-23 | 中国人民解放军陆军军医大学 | 氧化铈纳米簇在改善慢性肾病中的应用 |
| AU2023424695A1 (en) * | 2023-01-18 | 2025-08-28 | Applause Pharma Co., Ltd. | Pharmaceutical composition having, as active ingredient, cerium compound that contains trivalent cerium |
| CN116850147B (zh) * | 2023-06-05 | 2024-05-14 | 中南大学 | Ppc纳米颗粒、其制备方法以及在治疗心肌梗死的药物中的应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2809637B1 (fr) | 2000-06-05 | 2003-01-24 | Rhodia Terres Rares | Dispersion colloidale d'un compose de cerium ou d'un compose de cerium et d'au moins un autre element choisi parmi les terres rares et des metaux de transition et comprenant un acide amine |
| JP3768401B2 (ja) | 2000-11-24 | 2006-04-19 | Necエレクトロニクス株式会社 | 化学的機械的研磨用スラリー |
| JP3586711B2 (ja) | 2000-12-27 | 2004-11-10 | 独立行政法人物質・材料研究機構 | ナノセリア粉末の製造方法 |
| JP3793802B2 (ja) | 2001-07-09 | 2006-07-05 | 独立行政法人物質・材料研究機構 | 個々の粒子がナノサイズに分離したセリア粉末の製造法 |
| US7563457B2 (en) | 2001-10-02 | 2009-07-21 | The Regents Of The University Of California | Nanoparticle assembled hollow spheres |
| US7534453B1 (en) | 2002-09-05 | 2009-05-19 | University Of Central Florida Research Foundation, Inc. | Cerium oxide nanoparticles and use in enhancing cell survivability |
| KR100486959B1 (ko) * | 2003-01-29 | 2005-05-03 | 한국화학연구원 | 나노 크기의 세리아 제조방법 |
| EP1765280A1 (fr) | 2004-06-28 | 2007-03-28 | Procyte Corporation | Procédés et composition pour la prévention et le traitement de l"hyperpigmentation de la peau |
| WO2007002662A2 (fr) | 2005-06-27 | 2007-01-04 | Edward Via Virginia College Of Osteopathic Medicine | Capacites de nanoparticules d'oxyde de cerium anti-inflammatoires, radioprotectrices et renforçant de la longevite |
| WO2008002323A2 (fr) | 2005-12-23 | 2008-01-03 | Eastman Kodak Company | Production de grains d'oxyde métallique contenant du cérium |
| WO2008030815A2 (fr) * | 2006-09-05 | 2008-03-13 | Cerion Technology, Inc. | Procédé de préparation de nanoparticules de dioxyde de cérium |
| WO2009012425A2 (fr) | 2007-07-19 | 2009-01-22 | Logigal Therapeutics, Inc. | Compositions comprenant des antagonistes des leucotriènes et des nsaid, et leurs méthodes d'utilisation |
| DE102007062571A1 (de) | 2007-12-22 | 2009-06-25 | Evonik Degussa Gmbh | Ceroxid und Schichtsilikat enthaltende Dispersion |
| CN101683999A (zh) * | 2008-09-26 | 2010-03-31 | 杜小青 | 纳米二氧化铈制备方法 |
| CN102281945A (zh) * | 2008-12-17 | 2011-12-14 | 丝润技术有限公司 | 包含晶格经改造的二氧化铈纳米颗粒的燃料添加剂 |
| US8679344B2 (en) | 2008-12-17 | 2014-03-25 | Cerion Technology, Inc. | Process for solvent shifting a nanoparticle dispersion |
| IN2014DN10550A (fr) | 2012-06-13 | 2015-08-21 | Cerion Entpr Llc |
-
2013
- 2013-03-15 IN IN10550DEN2014 patent/IN2014DN10550A/en unknown
- 2013-03-15 DK DK13714425.9T patent/DK2861212T3/en active
- 2013-03-15 WO PCT/US2013/032318 patent/WO2013187980A1/fr not_active Ceased
- 2013-03-15 US US13/836,827 patent/US9034392B2/en active Active
- 2013-03-15 KR KR1020157000733A patent/KR101990070B1/ko not_active Expired - Fee Related
- 2013-03-15 ES ES13714425.9T patent/ES2617528T3/es active Active
- 2013-03-15 MX MX2014015251A patent/MX2014015251A/es active IP Right Grant
- 2013-03-15 AU AU2013274901A patent/AU2013274901B2/en not_active Ceased
- 2013-03-15 CN CN201380030839.3A patent/CN104812375B/zh not_active Expired - Fee Related
- 2013-03-15 EP EP13714425.9A patent/EP2861212B1/fr not_active Not-in-force
- 2013-03-15 JP JP2015517244A patent/JP6174692B2/ja not_active Expired - Fee Related
- 2013-03-15 CA CA2875206A patent/CA2875206C/fr not_active Expired - Fee Related
-
2015
- 2015-04-20 US US14/690,781 patent/US9533007B2/en active Active
-
2016
- 2016-12-22 US US15/388,700 patent/US9962406B2/en active Active
-
2018
- 2018-05-07 US US15/972,773 patent/US10729717B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015525228A (ja) | 2015-09-03 |
| WO2013187980A1 (fr) | 2013-12-19 |
| US20180250333A1 (en) | 2018-09-06 |
| JP6174692B2 (ja) | 2017-08-02 |
| US9962406B2 (en) | 2018-05-08 |
| CN104812375B (zh) | 2017-08-22 |
| EP2861212A1 (fr) | 2015-04-22 |
| KR101990070B1 (ko) | 2019-06-17 |
| AU2013274901A1 (en) | 2014-12-18 |
| US20130337083A1 (en) | 2013-12-19 |
| AU2013274901B2 (en) | 2017-09-14 |
| ES2617528T3 (es) | 2017-06-19 |
| US20150231174A1 (en) | 2015-08-20 |
| US9533007B2 (en) | 2017-01-03 |
| CA2875206C (fr) | 2020-07-14 |
| MX2014015251A (es) | 2015-04-13 |
| KR20150028293A (ko) | 2015-03-13 |
| DK2861212T3 (en) | 2017-03-06 |
| CA2875206A1 (fr) | 2013-12-19 |
| CN104812375A (zh) | 2015-07-29 |
| US9034392B2 (en) | 2015-05-19 |
| US20170100430A1 (en) | 2017-04-13 |
| US10729717B2 (en) | 2020-08-04 |
| EP2861212B1 (fr) | 2016-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN10550A (fr) | ||
| PH12019501662A1 (en) | FORMULATION FOR ANTI-a4á7 ANTIBODY | |
| BR112014013481A2 (pt) | processo para a oxidação de alcanos com o uso de uma alkb alcano 1-mono-oxigenase | |
| BR112015002372A2 (pt) | composições e métodos para a redução do teor de álcool no sangue | |
| EP2665697A2 (fr) | Procédé pour l'hydratation de butènes mélangés pour produire des alcools mélangés | |
| MX378180B (es) | Composicion para la reduccion del encrespado del cabello | |
| WO2013158744A3 (fr) | Nanoparticules de cérium et acides aminés | |
| BR112014002940A2 (pt) | uso e composição agroquímica de dibutilamidas de ácido carboxílico | |
| IN2014MN01552A (fr) | ||
| IN2014DN06537A (fr) | ||
| WO2013024013A3 (fr) | Procédé pour la préparation de complexes de 68ga | |
| MY166900A (en) | Anti-ageing composition containing dehydrogenated abietic acid as active ingredient | |
| IN2014MN01469A (fr) | ||
| IN2012DE00497A (fr) | ||
| GB2512777A (en) | Fatty acid ester compositions for use as emollients | |
| MX2015005406A (es) | Hidrogenacion de productos de isohexida para color mejorado. | |
| WO2011146167A3 (fr) | Procédés d'hydroalkylation | |
| WO2014016352A3 (fr) | Procédé | |
| BR112014017587A8 (pt) | métodos e formulações para o tratamento de deficiências de ácido siálico | |
| HK1223559A1 (zh) | 用於促性腺激素的配方 | |
| IN2015DN03169A (fr) | ||
| NZ615623A (en) | Chemical composition with hydrogen peroxide and a nanoemulsion of long-chained alcohols | |
| AR098023A1 (es) | Un proceso para preparar isoxaflutol | |
| WO2014104989A8 (fr) | Compositions pharmaceutiques comprenant de l'aripiprazole | |
| BR112015023146A2 (pt) | levedura recombinante e método para produzir etanol com uso da mesma |